Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Dose-Ranging Trial of Propofol-Only and Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging

NCT07369128 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT07369128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07369128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Dose-Ranging Trial of Propofol-Only and Dexmedetomidine-Propofol in Children Undergoing Magnetic Resonance Imaging
Lead sponsor
Boston Children's Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
June 30, 2026
Completion date
March 31, 2028
Enrollment
105 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dexmedetomidine, emergence delirium, anesthesia, mri sedation, pediatric sedation, propofol dosage, recovery time